Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ARIAD Pharmaceuticals Inc (NASDAQ:ARIA)

23.75
Delayed Data
As of Jan 20
 +0.05 / +0.21%
Today’s Change
4.37
Today|||52-Week Range
23.81
+90.92%
Year-to-Date
Shire's (SHPG) ADHD Candidate's NDA Accepted by FDA
Jan 20 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: ARIAD to be Acquired for $5.2B, Vertex Outlook Falls Short
Jan 11 / Zacks.com - Paid Partner Content
Abbvie (ABBV) Imbruvica Approved in Lymphoma Indication
Jan 20 / Zacks.com - Paid Partner Content
Valeant: on the rebound
Jan 10 / FT.com - Paid Partner Content
Allergan (AGN) Rhofade Cream for Rosacea Approved in U.S.
Jan 20 / Zacks.com - Paid Partner Content
After ARIAD's Acquisition, These 3 Cancer Drug Stocks Could Be Next
Jan 10 / MotleyFool.com - Paid Partner Content
Can The Uptrend Continue for ARIAD Pharmaceuticals (ARIA)?
Jan 20 / Zacks.com - Paid Partner Content
4 Stocks in Focus as Biotech M&A Hopes Surge on Takeda-ARIAD Deal
Jan 10 / Zacks.com - Paid Partner Content
5 Expensive Drugs That Could End Up in Trump's Crosshairs
Jan 18 / MotleyFool.com - Paid Partner Content
ARIAD Pharma Stock Gains on Acquisition Deal with Takeda
Jan 10 / Zacks.com - Paid Partner Content
Becton, Dickinson Commercially Launches Precise WTA Kits
Jan 18 / Zacks.com - Paid Partner Content
European stocks eyeing soft open after Wall St dips
Jan 09 / FT.com - Paid Partner Content
Jazz Begins Phase III Study for Label Expansion of Defitelio
Jan 18 / Zacks.com - Paid Partner Content
US biotechnology stocks show strength at start of 2017
Jan 09 / FT.com - Paid Partner Content
Sanofi Diabetes Drug Suliqua Wins EU Marketing Approval
Jan 18 / Zacks.com - Paid Partner Content
Why Ariad Pharmaceuticals, VCA, and Exact Sciences Jumped Today
Jan 09 / MotleyFool.com - Paid Partner Content
Baxter (BAX): Sluggish Macro Environment Mars Prospects
Jan 18 / Zacks.com - Paid Partner Content
Takeda/Ariad: rough diamond
Jan 09 / FT.com - Paid Partner Content
These 3 Stocks Have Doubled Since Election Day
Jan 17 / MotleyFool.com - Paid Partner Content
Why Ariad Pharmaceuticals Stock Soared Today
Jan 09 / MotleyFool.com - Paid Partner Content
ArQule (ARQL) Catches Eye: Stock Moves 7.2% Higher
Jan 13 / Zacks.com - Paid Partner Content
Japan's Takeda to buy Ariad of the US for $5bn
Jan 09 / FT.com - Paid Partner Content
These 3 Stocks Quadrupled in Just 1 Year
Jan 13 / MotleyFool.com - Paid Partner Content
AA Still Kicks Off Q4? It???s Yellow Pages Mentality
Jan 09 / Zacks.com - Paid Partner Content
ARIAD: Acquisition by Takeda Bodes Well, Competition a Risk
Jan 13 / Zacks.com - Paid Partner Content
The FDA Approved Fewer Drugs in 2016: Here's Why
Jan 09 / Zacks.com - Paid Partner Content